Leonid S Metelitsa

15PUBLICATIONS
53CO-AUTHORS
NanomaterialsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nanofabrication, growth and self assemblyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 21, 2025
Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T Cells.

Amy N Courtney, Xin Zhou, Gengwen Tian

|Jan 17, 2025
PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function.

Gengwen Tian, Gabriel A Barragan, Hangjin Yu

|Oct 01, 2024
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.

Xin Zhou, Ying Wang, Zhangqi Dou

|May 14, 2024
A milestone method to make natural killer T cells.

Leonid S Metelitsa

|Jan 09, 2024
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.

Andras Heczey, Xin Xu, Amy N Courtney

|May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.

Andras Heczey, Xin Xu, Amy N Courtney

Pageof 3

Frequent Collaborators

8 joint publications

Amy N Courtney

7 joint publications

Xin Xu

6 joint publications

Andras Heczey

3 joint publications

Gengwen Tian